Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
Emanuele RandoEmanuele RandoFlavio SangiorgiFrancesca CataniaElisa LeoneAlessandra OlivaFrancesco Di GennaroBarbara FioriFrancesca CancelliSara FigliomeniFrancesca BobbioFederica SaccoDavide Fiore BavaroLucia DiellaAlessandra BelatiAnnalisa SaracinoClaudio Maria MastroianniMassimo FantoniRita MurriPublished in: The Journal of antimicrobial chemotherapy (2024)
Piperacillin/tazobactam use might not be associated with increased mortality in treating third-generation cephalosporin-resistant E. coli bloodstream infections when the MIC is <8 mg/L.